Clinical Trial Update: Neuroprotective Effect of Butylphthalide for Cardiac Arrest Patients [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is recruiting to evaluate the neuroprotective effects of Butylphthalide in cardiac arrest patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Arrest

Drugs mentioned

• Butylphthalide (butylphthalide)

Snippet

Sponsor: Tang Ziren | Conditions: Butylphthalide, Cardiac Arrest | Phase 4 | Status: RECRUITING